Viatris Inc. (VTRSV) - 5i Research

Viatris Inc. (VTRSV)
- Cap: $18.79B
- View VTRSV Profile
- View Questions on VTRSV

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Viatris Inc. (VTRSV)
- Cap: $18.79B
- View VTRSV Profile
- View Questions on VTRSV

Q: Hi Peter snd staff

A question yesterday asked to rank some stocks -appears you are warming up to Viatris? Some commentators worry about drugs coming off patent - some say it is so cheap it should be re rated? Safe for a long term hold with dividend and done growth?

Thanks for all you do
Dennis

Read Answer Asked by Dennis on November 17, 2021